Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Creager

Showing results (431-440 of 516) with videos related to

Pageof 52
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2025
Autism-associated <i>SCN2A</i> deficiency disrupts cortico-striatal circuitry in human brain assembloidsXiaoling Chen, Jingliang Zhang, Jiaxiang Wu, et al.
JAMA|May 1, 2018
Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical TrialMary M McDermott, Bonnie Spring, Jeffrey S Berger, et al.
Journal of Clinical Microbiology|June 29, 2022
A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as OmicronEric Lai, Emily B Kennedy, Jean Lozach, et al.
Journal of Virology|July 3, 2020
Genetically and Antigenically Divergent Influenza A(H9N2) Viruses Exhibit Differential Replication and Transmission Phenotypes in Mammalian ModelsJessica A Belser, Xiangjie Sun, Nicole Brock, et al.
Journal of the American Chemical Society|March 13, 2013
A homogeneous chemiluminescent immunoassay methodHashem Akhavan-Tafti, Dean G Binger, John J Blackwood, et al.
Journal of the American College of Cardiology|May 15, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt, Marcus D Flather, Werner Hacke, et al.
American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.
The New England Journal of Medicine|March 15, 2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt, Keith A A Fox, Werner Hacke, et al.
The American Journal of Tropical Medicine and Hygiene|April 2, 2020
Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19)David M Brett-Major, Elizabeth R Schnaubelt, Hannah M Creager, et al.
American Heart Journal|May 13, 2015
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' CollaborationAlex Pitcher, Jonathan Emberson, Ronald V Lacro, et al.
Pageof 52

Showing results (431-440 of 516) with videos related to

Sort By:
Pageof 52
Biorxiv : the Preprint Server for Biology|June 12, 2025
Autism-associated <i>SCN2A</i> deficiency disrupts cortico-striatal circuitry in human brain assembloidsXiaoling Chen, Jingliang Zhang, Jiaxiang Wu, et al.
JAMA|May 1, 2018
Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical TrialMary M McDermott, Bonnie Spring, Jeffrey S Berger, et al.
Journal of Clinical Microbiology|June 29, 2022
A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as OmicronEric Lai, Emily B Kennedy, Jean Lozach, et al.
Journal of Virology|July 3, 2020
Genetically and Antigenically Divergent Influenza A(H9N2) Viruses Exhibit Differential Replication and Transmission Phenotypes in Mammalian ModelsJessica A Belser, Xiangjie Sun, Nicole Brock, et al.
Journal of the American Chemical Society|March 13, 2013
A homogeneous chemiluminescent immunoassay methodHashem Akhavan-Tafti, Dean G Binger, John J Blackwood, et al.
Journal of the American College of Cardiology|May 15, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt, Marcus D Flather, Werner Hacke, et al.
American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.
The New England Journal of Medicine|March 15, 2006
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsDeepak L Bhatt, Keith A A Fox, Werner Hacke, et al.
The American Journal of Tropical Medicine and Hygiene|April 2, 2020
Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19)David M Brett-Major, Elizabeth R Schnaubelt, Hannah M Creager, et al.
American Heart Journal|May 13, 2015
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' CollaborationAlex Pitcher, Jonathan Emberson, Ronald V Lacro, et al.
Pageof 52